37
Endovascular treatment for pulmonary embolisms
The only one of its kind on the market today , this technology is used by interventional cardiologists , vascular surgeons and pulmonologists for the treatment of pulmonary embolism and deep vein thrombosis . The technology helps improve the efficiency of the thrombolytic process and reduce the treatment time and total lytic dose thereby reducing the associated bleeding risk and overall cost of therapy . The Dallas campus was one of the first sites in the US to deploy the system in calendar year 2018 . Four years later , the endovascular treatment technology continues to be indicated for :
• Controlled and selective infusion of physicianspecified fluids , including thrombolytics , into the peripheral vasculature
• Infusion of solutions into the pulmonary arteries
• The ultrasound facilitated , controlled and selective infusion of physician-specified fluids , including thrombolytics , into the vasculature for the treatment of pulmonary embolism
• Intended for the treatment of pulmonary embolism patients with ≥ 50 % clot burden in one or both main pulmonary arteries or lobar pulmonary arteries , and evidence of right heart dysfunction based on right heart pressures ( mean pulmonary artery pressure ≥ 25 mmHg ) or echocardiographic evaluation
Renal denervation : Dallas campus leading critical studies
There are several studies for renal denervation work being conducted on the Baylor Dallas campus , including Spyral On Med , Spyral Off Med and Spyral Dystal . Additional studies are in review . The Spyral On Med trial completed enrolling at the end of March 2022 , and results of the trial are anticipated to be available around the end of calendar year 2022 . There will be submission to the FDA by the study sponsor . With the increasing number of Americans living with hypertension , the Dallas cardiovascular medical staff and the team for the new Hypertension Center will be following the outcomes closely .
In the prior year for Spyral On Med , Spryal Off Med and Spyral Dystal , the Dallas campus was recognized as the top enrolling site nationwide for all three studies .
Baylor Scott & White Heart and Vascular Hospital - Dallas | Interventional Cardiology